Coalition Letter to Congress in Support of the Safe Step Act


The Safe Step Act takes a common sense and balanced approach to improving patient access by ensuring that commercial health plans provide an expeditious, transparent, and reasonable step therapy appeals process. Under the Act, plans must respond to step therapy appeals within 24-72 hours, and base their determinations on sound medical reasoning and the necessity to the patient. Plans must also make their appeals process available online to both patients and providers, including the information needed to submit a successful appeal. To support patient access to the right treatment at the right time, we urge you to seek the passage of H.R. 2279/S. 2546, the Safe Step Act expeditiously.

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorCommunity Health Charities logo

Copyright © 1996-2023 National Psoriasis Foundation/USA

Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).

NPF does not endorse or accept any responsibility for the content of external websites.

NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.